drugset
drugset / Trial / NCT04530383

Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function

NCT04530383 ↗

Phase 2 Recruiting 30 enrolled University of Kansas Medical Center
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the efficacy of metformin to improve airway ion channel function in those with CF-related diabetes (CFRD)

Timeline

Start
2022-02-14
Primary completion
2027-12-30
Completion
2028-07-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 1000 mg —

Indications

cystic fibrosis cystic fibrosis-related diabetes